No Picture
News

Weekly Policy Blog: FDA Guidances on 510(k) Submissions; Actuarial Review of Biomarker Testing Coverage Bill 

FDA Issues Three Guidances on Premarket Notification [510(k)] Program  On September 7, 2023, the U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) issued three new draft guidance documents addressing premarket […]

News

Zynex Announces Share Repurchase Program

ENGLEWOOD, Colo., Sept. 11, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced […]

News

Biotech megarounds galore; New leaders at Novartis, Biogen; State of play for GLP-1 in NASH; Inside Illumina’s CEO search; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

No Picture
News

ALLOSOURCE ANNOUNCES POSTER FEATURING PROCHONDRIX CR OSTEOCHONDRAL ALLOGRAFT CLINICAL OUTCOMES AT THE 17TH INTERNATIONAL CARTILAGE REGENERATION & JOINT PRESERVATION SOCIETY (ICRS) WORLD CONGRESS

CENTENNIAL, Colo. , Sept. 8, 2023 /PRNewswire/ — AlloSource®, one of the United States leading innovators and manufacturers of cartilage for joint preservation, today announced that its research on positive prospective clinical outcomes for the […]